On 2024-11-12, Zenas BioPharma, Inc. (ZBIO) announced earnings per share of $-5.02 for the fiscal quarter ending 2024-09-30, beating the average analyst estimate of $-13.00.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-11-12 | 2024-09-30 | $-13.00 | $-5.02 |